In vitro activity of trovafloxacin against Chlamydia pneumoniae.
The in vitro susceptibilities of 12 strains of Chlamydia pneumoniae to a new quinolone, trovafloxacin, and ofloxacin, doxycycline, erythromycin, and azithromycin were determined. The activity of trovafloxacin was similar to that of ofloxacin, with a MIC at which 90% of the isolates are inhibited and...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1997
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164061/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303410/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.2033 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|